Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Interest & Investment Income: 2012-2025

Historic Interest & Investment Income for CorMedix (CRMD) over the last 12 years, with Sep 2025 value amounting to $1.6 million.

  • CorMedix's Interest & Investment Income rose 181.71% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 22.33%. This contributed to the annual value of $2.6 million for FY2024, which is 3.84% down from last year.
  • Latest data reveals that CorMedix reported Interest & Investment Income of $1.6 million as of Q3 2025, which was up 88.22% from $828,949 recorded in Q2 2025.
  • CorMedix's Interest & Investment Income's 5-year high stood at $1.6 million during Q3 2025, with a 5-year trough of $3,022 in Q3 2021.
  • Moreover, its 3-year median value for Interest & Investment Income was $612,082 (2024), whereas its average is $729,662.
  • In the last 5 years, CorMedix's Interest & Investment Income slumped by 94.23% in 2021 and then surged by 4,102.08% in 2022.
  • CorMedix's Interest & Investment Income (Quarterly) stood at $4,367 in 2021, then surged by 4,102.08% to $183,505 in 2022, then skyrocketed by 719.17% to $765,241 in 2023, then fell by 27.62% to $510,385 in 2024, then surged by 181.71% to $1.6 million in 2025.
  • Its Interest & Investment Income was $1.6 million in Q3 2025, compared to $828,949 in Q2 2025 and $566,797 in Q1 2025.